chrisvoncsefalvay/vaers-outcomes huggingface dataset:
On Saturday November fifth 2022 my head was stuffy and I was very tired, I slept a lot overnight I woke up Sunday morning still feeling tired and stuffy. I took a home COVID-19 test and it was positive. I called my medical practice and was prescribed PAXLOVID by the Physician on call. I began taking PAXLOVID by about eleven Sunday November six 2022. I continued to feel tired and stuffy through tat Sunday until Monday afternoon around four PM when I began to feel better.  By Wednesday November ninth 2022 I was feeling good but still testing positive. My first negative test was on Friday November eleventh 2022.
Having temperature between 99 and less than 101,has been on and off for 8 days; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Having temperature between 99 and less than 101,has been on and off for 8 days) in an 81-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 03-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced PYREXIA (Having temperature between 99 and less than 101,has been on and off for 8 days). At the time of the report, PYREXIA (Having temperature between 99 and less than 101,has been on and off for 8 days) outcome was unknown. Not Provided          Concomitant information not provided. Treatment included Tylenol and Fever
CLIENT CONTRACTED COVID DESPITE FULLY VACCINATED AT TIME OF EXPOSURE AND POSITIVE PCR TEST.  HOSPITALIZED INPATIENT AND RECEIVED MONOCLONAL ANTIBODIES TREATMENT.
2 days after the vaccination she developed dry mouth, dry irritated eyes, tongue irritation, and mild disequilibrium.  3 weeks later, the eye symptoms have improved.  She still has dry mouth and mild disequilibrium.  The symptoms may be improving currently
swelling & tenderness over site x 7 hrs & limp x 2 days;
After strong immune response several hours after the second shot (fever/chills/headache), I continued to have extreme and ongoing fatigue for weeks following, despite adequate rest and sleep. I determined that I was anemic and started taking an Iron supplement, which resolved the extreme fatigue.
Vertigo aggravated; Cold Sore on the lips; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of ORAL HERPES (Cold Sore on the lips) and VERTIGO (Vertigo aggravated) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for an unknown indication.     Patient medication history was not provided by the reporter.     On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, the patient experienced ORAL HERPES (Cold Sore on the lips). On 07-Mar-2021, the patient experienced VERTIGO (Vertigo aggravated). The patient was treated with MECLIZINE [MECLOZINE] for Vertigo, at a dose of 1 UNK. At the time of the report, ORAL HERPES (Cold Sore on the lips) had resolved and VERTIGO (Vertigo aggravated) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Spotting around Ovulation was reported as worsened; Caller states it seems more pronounced and heavier this second month; experiencing spotting around the ovation time; This is a spontaneous report from a contactable consumer. This female consumer (reported for herself):  A 28-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; solution for injection, Lot Number: EW0183), via unspecified route of administration, in left arm on 20May2021 (at the age of 28-year-old) as a dose 2, single for COVID-19 immunization. The patient medical history included anxiety. The concomitant medication of the patient included escitalopram oxalate (LEXAPRO) for anxiety. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot Number:EW0158), via unspecified route of administration on 29Apr2021, as a dose 1, single for COVID-19 immunization. On 04Jun2021 the patient experienced spotting around the ovation time. On an unspecified date of Jul2021 patient reported that it was worsened and also reported that it seems more pronounced and heavier this second month. The patient reported that she had a change in her menstrual cycle. Patient had both doses of the vaccine and for the past 2 months, she has had a similar thing that had never happened before. Patient stated that she had spotting around ovulation and it seems odd and she was not sure how much data was being reported about it.The patient was more pronounced and heavier in second month. Patient also stated that the second time she was noticing it and this time it was more obvious. Patient stated that last month she didn't write down exactly how long, but it was a short one day thing in June and then she got her period 2 weeks later so that would check out and on Monday it was day 17 of her cycle and she had spotting. The patient queried if there was a way to access any mass collection of information on her side effect. The patient not received any treatment for spotting around the ovation time. The outcome for spotting around the ovation time and it seems more pronounced and heavier this second month was not recovered. The outcome for spotting around ovulation was reported as worsened was unknown.  Follow-up attempts are completed. No further information is expected.
minimal soreness; 2nd dose given beyond 35 days of 1st; crystal clear vision that lasted for 30 minutes; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose given beyond 35 days of 1st), THERAPEUTIC RESPONSE UNEXPECTED (crystal clear vision that lasted for 30 minutes) and PAIN (minimal soreness) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032B21A and 040A21A) for COVID-19 vaccination.     Concurrent medical conditions included Chronic fatigue syndrome.   On 27-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 07-Jun-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose given beyond 35 days of 1st). 07-Jun-2021, the patient experienced THERAPEUTIC RESPONSE UNEXPECTED (crystal clear vision that lasted for 30 minutes). On an unknown date, the patient experienced PAIN (minimal soreness). On 07-Jun-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose given beyond 35 days of 1st) and THERAPEUTIC RESPONSE UNEXPECTED (crystal clear vision that lasted for 30 minutes) had resolved. At the time of the report, PAIN (minimal soreness) outcome was unknown.            Action taken with mRNA-1273 in response to the event was not applicable.  No concomitant medications provided. No treatment information provided.   Most recent FOLLOW-UP information incorporated above includes: On 30-Jun-2021: Follow up information included additional event
Hospitalized with 4 day history of cough and fatigue, fell and now with pain and a positive COVID test. No Covid directed therapy
My left arm (site of vaccine), had 3 red blotches, warm to the touch and a little swollen and sore.  Was not sure if I needed to mention this reaction,  3/27/21 Saturday,  seems to be getting better. Did not seek any further treatment because I'm feeling fine. Did not seek treatment.
Swelling and redness at reaction site. Diameter was about 4. Gave BENADRYL cleared up in 3 days.
Pt admited on 8/12/21 via ems from scene of poss atv accident. Pt had been struck by vehicle. GCS 3. Pt had obvious facial fractures, transferred to hospital as level 1 trauma. On arrival, King airway was exchanged for an ET tube.  Chest tube was placed on the right for pneumothorax. CT showed right sided subdural hematoma. Tested for COVID on 8/12/2021.  Pt in still an inpatient.
came down with it; cough; Initial information received on 14-Dec-2022 regarding an unsolicited valid Social media non-serious case received from a consumer/non-health care professional.  This case involves an unknown age female patient who came down with it and cough while receiving vaccine influenza vaccine.  The patient's past medical history, medical treatment(s), vaccination(s), concomitant(s) and family history were not provided.    On an unknown date, the patient received unknown dose of suspect influenza vaccine produced by unknown manufacturer (strength, formulation, lot number, expiry date: not reported) via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date the patient came down with it (Influenza) and cough (unknown latency) following the administration of influenza vaccine.  It was reported as "Got her Flushot Nov 30th during a check-up at her PCPs. Two days later, her husband came down with it. Was going to get his on Dec 14th during his check-up for A1C. 4 days after, she came down with it which she suppose is because she hadn't yet had 14 days after her flu shot so my body hadn't developed full immunity. They are still recuperating. Can't get rid of cough yet! she wanted to say though that she believe they caught it at my doctor's waiting room (she's a pediatrician also) and there was a kid coughing up a storm. Funny thing is that the day before her husband started having symptoms, he got together with 5 friends who all have chronic underlying conditions and neither one of them got sick. Not all of them were vaccinated."  No lab data was reported.  Action taken was not applicable.  It was not reported if the patient received a corrective treatment for the events.  At time of reporting, the outcome was Unknown.
Staff returned to facility 48h after vaccines to read PPDs administered. Nursing Director reported to staff the patient had an allergic reaction to the PN vaccine which resulted in her being hospitalized.
About 30 min. after injections, complained of not feeling well and had difficulty swallowing. Resp. and pulse okay. Swallowing difficulty worsened. Benadryl IM and Epinephrine IM given. Vital Signs stable. No cyanosis. Treated with Benadryl and prednisone dose pack.
Body aches; Chills; Headache; Possibly a fever; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Body aches), CHILLS (Chills), HEADACHE (Headache) and PYREXIA (Possibly a fever) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Diabetic. Concomitant products included METFORMIN and GLIMEPIRIDE for Diabetes.    On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Jan-2021, the patient experienced MYALGIA (Body aches), CHILLS (Chills), HEADACHE (Headache) and PYREXIA (Possibly a fever). At the time of the report, MYALGIA (Body aches), CHILLS (Chills), HEADACHE (Headache) and PYREXIA (Possibly a fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment activities for event was reported as none.; Sender's Comments: Limited information regarding the events has been provided at this time and a causal relationship cannot be excluded
Since day of injection (11 days ago)  I still continue to see fist size redness around the injection site. Skin is warm to the touch and itchy. Benadryl cream is applied and is somewhat effective. Have had similar reactions to flu shot although not this large in diameter... red mark is about the size of a nickel and can last up to 12 months.
Patient felt slight tingling in fingers.  Called her back at 3:30pm and she said it seemed better but her hand and fingers still felt a little "weird".   Vaccine definitely went into deltoid - took picture of site with pts phone and mine.
She began having swelling around her eyes on 08/05/2023 into 08/06/2023, gave Bendryl but that didn't help. Started having hives on 08/07/2023. Grandmother called clinic on 08/08/2023 to report symptoms. Recommended for her to call childs PCP or go to urgent care or ER today. Attempted to call grandmother for an update on 08/17/2023 and left voicemail.
Pt reported dizziness after receiving zoster vaccine. No swelling or shortness of breath.
Mom reports pt "cried all night" p/recvd 1st DTP vax; did not take temp, did give ASA substitute;
SIRVA?  About 4 hours after receiving the vaccine, I experienced strong pain at the injection site that radiated down to my wrist.  This lasted only about 1 hour and I am mentioning it just in case it?s related to my issue.    Two or three days after receiving the vaccine, I developed a burning pain deep in my shoulder area that was noticeable only when I swung my arm backwards, such as when walking.  The pain felt like it was deep in my shoulder joint.  I have attempted to locate the source of the pain by pressing my fingers deeply up into my armpit; however, I feel no pain when pressing into my armpit in this manner.    The pain level varies but has not subsided and continues to be noticeable when swinging my arms while walking. I didn?t strain, stretch, or otherwise stress my shoulder in any way that would cause this pain.    The pain has now become noticeable in the front of my shoulder, as well.   When I palpate the front of my shoulder, I feel distinct tenderness and pain.   My husband, who is an orthopedic surgeon, palpated the area and noted that the major pain seems to be coming from my biceps tendon.    I continue to feel pain in the biceps tendon area when I press on that area, as well as the pain deep within the shoulder that I cannot locate via palpation.  My main concern is whether I need to take my first dose of the Moderna vaccine again in the event I have SIRVA.
A cluster on red, irritated, and painful blisters (vesicles) appeared on face near left nostrils and inside right nostril.
This case was reported by a consumer via call center representative and described the occurrence of erythema of extremities in a female patient who received SHINGRIX for prophylaxis. On 24th July 2018, the patient received the 1st dose of SHINGRIX (subcutaneous). On 24th July 2018, less than a day after receiving SHINGRIX, the patient experienced erythema of extremities, swelling arm and vaccine administered at inappropriate site. On an unknown date, the outcome of the erythema of extremities and swelling arm were not recovered/not resolved and the outcome of the vaccine administered at inappropriate site was unknown. It was unknown if the reporter considered the erythema of extremities and swelling arm to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. It was administered in the fatty tissue in the back of the arm instead of into the deltoid muscle, which led to inappropriate site of vaccination. When he got home his arm was red and swollen. This case has been linked with the case US2018134619, reported by the same reporter.
12/9/21 23-year-old female here with new problem.  Patient states 2 days ago she developed congestion sore throat mild headache.  She does have a dry cough but no shortness of breath.  Patient does not know Covid exposure but desires testing.
Arm swelled up on the pneumococcal side. Was able to go to work the next day but went home early because got sicker and sicker. Still don't feel well. Blood suger is up over 200, diabetic.
Pain, fever, and arm pain on 5/20/08. Blisters on both arms. One week later Pt. put OTC meds on blisters and it helped stop itching.
Restless leg. He started with symptoms the day he received the vaccine. He reports Flu-like symptoms for 2 days following the vaccine. He has not had any treatment. I will be starting treatment.  He is recovering from gastroenteritis at this time, which was his primary concern today when reporting the side effect of the vaccine.
Information has been received from a mother concerning her 10-month-old son with no allergies, who was exposed to a sibling who was vaccinated on 09-Dec-1999 with a dose of Varivax (Oka/Merck).  The patient was not taking any medications.  On 02-Jan-2000 the patient was admitted to the hospital because he had pneumonia.  The mother reported that when her son left the hospital after the pneumonia, he was readmitted that night because he had spots on his scalp.  He was diagnosed with full blown varicella on his scalp, bottom, mouth, privates and eventually throughout his whole body.  He was in the hospital for 12 days.  A sweat test was performed on an unspecified date.  On an unspecified date, the patient recovered.  The patient now has lung problems, skin problems, allergies and asthma.  The patient goes in the hospital about twice a year for his asthma and pneumonia.  He has received the Pneumovax 23 vaccine (MSD) for the pneumonia which has helped.  No product quality complaint was involved.  Additional information received for the physician's office indicates that the patient was last seen in the office in 2005.  The records were sent to storage, and therefore there were no vaccination records available.  The R.N. also reported that the patient's sister developed adverse events following a vaccine administration (WAES# 0802USA02660).  Additional information has been requested.
Developed early, adhesive capsulitis of left shoulder with impingement. Experiencing significant pain and limited range of motion.
DTaP & Hib given on 2/26/13. Baby fussy & irritable. Imms given on Tuesday. Resolved on Saturday 3/2/13.
No other AE; Caller is a medical assistant who reports administration of vaccine following temperature excursion. Patient did not have any symptoms or adverse effects of receiving vaccine. No further information provided. No other AE/no PQC.         ?    Names; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions, drugs allergies and reactions were not provided. Concomitant medications included sterile diluent.  On 13-APR-2022, the patient was vaccinated with a wrongly stored vaccine measles, mumps, rubella and varicella (oka-merck) virus vaccine live (recombinant human albumin  rHA) (PROQUAD) 0.5 milliliter/once, lot number U028179, expiration date reported as 08-MAR-2023, (strength, and route of administration were not provided) (product storage error). The patient did not have any symptoms or adverse effects for the administration of the vaccine. The temperature of the excursion of the vaccine was -13 Celsius degree (C) for a time of 1 hour.
Information has been received from a nurse concerning a female with prednisone, antidepressants, environmental items allergies, anxiety and asthma who on 21-NOV-2008 was vaccinated with the first dose of PNEUMOVAX 23. Concomitant therapy included KLONOPIN, minerals (unspecified) (+) vitamins (unspecified), FLONASE, ADVAIR, albuterol, ZYRTEC, ZADITOR and PATANASE NASAL SPRAY. The patient developed sepsis and cellulitis after her first vaccination with PNEUMOVAX 23. On 22-NOV-2008 the day after vaccination, the patient developed chills and fever and her arm swelled from elbow to deltoid. The patient went to emergency room and was admitted to hospital for three days. While hospitalized she received oxacillin. On unspecified date, the patient recovered from sepsis, cellulitis and chills. Additional information has been requested.
Activation of Ménière's disease; Vertigo; This spontaneous case was reported by a consumer and describes the occurrence of MENIERE'S DISEASE (Activation of Ménière's disease) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MENIERE'S DISEASE (Activation of Ménière's disease) (seriousness criterion medically significant) and VERTIGO (Vertigo). At the time of the report, MENIERE'S DISEASE (Activation of Ménière's disease) and VERTIGO (Vertigo) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication use information was not provided by reporter.  Treatment medication use information was not provided by reporter.  Very limited information regarding the events has been provided at this time.  Further information has been requested.; Sender's Comments: Very limited information regarding the events has been provided at this time.  Further information has been requested.
asymptomatic, tested positive on binax rapid antigen test performed as follow up to known covid exposure
3rd dose of Shingrix on 28/Oct/2023; the first dose of Shingrix on 12/Jun/2018, the 2nd on 4/Dec/2021; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of drug dose administration interval too long in a 64-year-old female patient who received Herpes zoster (Shingrix) (batch number 7S7MF, expiry date 27-SEP-2025) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix  (1st dose received on 12th June 2018).   On 28-OCT-2023, the patient received the 3rd dose of Shingrix. On 04-DEC-2021, the patient received the 2nd dose of Shingrix. On 04-DEC-2021, not applicable after receiving Shingrix and an unknown time after receiving Shingrix, the patient experienced drug dose administration interval too long (Verbatim: the first dose of Shingrix on 12/Jun/2018, the 2nd on 4/Dec/2021). On 28-OCT-2023, the patient experienced extra dose administered (Verbatim: 3rd dose of Shingrix on 28/Oct/2023). The outcome of the drug dose administration interval too long and extra dose administered were unknown.   Additional Information: GSK Receipt Date: 30-OCT-2023 A pharmacist called to inform that a patient that that received the 2nd dose of Shingrix later than recommended schedule which led to lengthening of vaccination schedule. The patient received a 3rd dose of Shingrix which led to extra dose administered.  The reporter did not consent to follow-up.